Ivermectin–Fenbendazole Interaction
No well-characterized, clinically important drug–drug interaction between ivermectin and fenbendazole has been established in standard human interaction references. [1]
In veterinary medicine, ivermectin and fenbendazole are sometimes co-administered as separate products or as fixed-dose combinations to broaden parasite coverage, without a specific toxic pharmacologic interaction being identified in available studies. [2], [3]
Mechanistic Interaction Assessment
Ivermectin and fenbendazole are both anthelmintics with different primary antiparasitic targets, so no synergistic or antagonistic pharmacodynamic mechanism is required to explain their combined use in parasite control. [2]
Evidence From Co-Administration Studies (Veterinary)
In a feedlot heifer study, a fenbendazole oral drench plus an ivermectin pour-on regimen reduced worm eggs per fecal sample 98 days after treatment more than ivermectin pour-on alone. [2]
In the same report, the combined regimen improved feedlot and carcass performance compared with ivermectin pour-on or doramectin alone, supporting feasibility of co-administration for parasite burden reduction rather than identifying a harmful interaction. [2]
Evidence From Combination/Resistance Context
Anthelmintic resistance is common in livestock parasites, so outcomes with either drug (alone or in combination) may reflect resistance patterns rather than drug–drug interaction. [4]
In horses, fenbendazole and ivermectin differed in efficacy against cyathostome populations in fecal egg count reduction testing, indicating that co-use does not eliminate resistance concerns. [4]
Practical Safety Considerations
Potential risk is more plausibly related to dosing, formulation, and species-specific labeling rather than a specific ivermectin–fenbendazole interaction described in high-quality references. [2], [3]
Response to Suspected Adverse Effects
If adverse effects occur during antiparasitic therapy, immediate cessation of further dosing and prompt veterinary or clinical evaluation are recommended because toxicity and resistance-related treatment failure can be clinically indistinguishable at presentation. [2], [4]
Key Limitations of Available Evidence
Most available ivermectin–fenbendazole “interaction” information in the literature concerns parasite control strategies and resistance surveillance rather than controlled pharmacokinetic or clinical interaction trials establishing a definitive interaction magnitude. [2], [4]
Summary for Clinical Decision-Making
No definitive ivermectin–fenbendazole harmful interaction is established in accessible interaction references. [1]
Co-administration is used in veterinary contexts for parasite coverage, while resistance patterns can materially affect effectiveness. [2], [4]
Medication choice should therefore follow species-appropriate labeling and local resistance patterns rather than expectation of a specific pharmacologic interaction between the two drugs. [4]